Vigil Neuroscience, Inc. - VIGL Net Assets per Single Share
The stable operation of laboratories and computing capacities for molecular modeling provided the foundation for growth for Vigil Neuroscience (VIGL). The net asset value per ordinary share reflects capital dynamics, where the 0.87 level records fresh values. Development relies on the creation of innovative TREM2 therapies against Alzheimer's disease and strategic alliances with neuroimmunological research groups to protect patients' brains.
Vigil Neuroscience Inc. - analytical breakdowns and key metrics (VIGL)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:vigilneuro.com, VIGL
Book value per share measures the portion of equity attributable to a single security, allowing for an assessment of the actual value of net assets minus liabilities. By analyzing the book value per share trend, an investor in Vigil Neuroscience (VIGL) can monitor the level of cash reserves, which are critical for financing costly research into neurodegenerative pathologies in the absence of current commercial revenue.
Competitor analysis
Book Value per Share BIIB|NBIX: Book Value of One Share|Regencell Bioscience (RGC) - Net Assets per Single Share|AXSM (axsome.com) - Net Assets per Single Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Net Asset Value per Share Trevi Corp|Accounting Value per Share Praxis Precision Medicines|Net Assets per Single Share anavex.com|CBLL (CeriBell) - Book Value per Share|Net Assets per Share Prothena Corporation (PRTA)|ALEC (Alector) - Book Value per Share|Book Value of One Share Annexon Biosciences Inc. ANNX|Book Value per Share OMER (Omeros Corp.)|NGNE: Net Assets per Share|AC Immune SA (ACIU) - Net Assets per Single Share|Net Assets per Single Share Voyager Therapeutics Inc|NMRA - Accounting Value per Share|Accounting Value of a Share SCLX|Net Assets per Single Share Tevogen Bio Holdings TVGN|Equity per Share alphacognition.com (ACOG)|CGTX: Book Value per Share|IKT - Net Asset Value per Share|Cassava - Accounting Value per Share|ASRT: Book Value per Share|Net Assets per Single Share coyatherapeutics.com COYA|VTGN (Vistagen) - Accounting Value of a Share|Net Assets per Single Share OVID (Ovid Therapeutics Inc)|Net Asset Value per Share ABOS|CRVO (CervoMed Inc) - Net Assets per Single Share|Net Assets per Share alteritytherapeutics.com (ATHE)|Clene - Book Value per Share|Accounting Value per Share PepGen Inc PEPG|Book Value per Share JUNS (Jupiter Neurosciences Inc)|RLMD - Net Assets per Share|Book Value per Share ANVS|GRCE (Grace Therapeutics) - Net Asset Value per Share|Net Assets per Single Share Firefly Neuroscience, Inc (AIFF)|Equity per Share ANEW Medical, Inc.|Book Value per Share NRSN (NeuroSense Therapeutics)|Accounting Value per Share Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Book Value per Share|NRXS - Net Asset Value per Share|HSDT - Accounting Value per Share|PASG - Net Assets per Single Share|bionomics.com.au - Book Value per Share|Minerva Neurosciences Inc (NERV) - Net Assets per Share|Athira - Book Value per Share|Book Value of One Share ADXN|Net Assets per Single Share Alzamend Neuro, Inc. (ALZN)|Net Assets per Single Share CYCN (cyclerion.com)|PTIX - Net Assets per Single Share|Equity per Share Pasithea Therapeutics Corp KTTA|CRGT (Cortigent Medical) - Book Value per Share|Avenue Therapeutics Inc (ATXI) - Net Asset Value per Share|BCLI: Accounting Value per Share|CARA (caratherapeutics.com) - Book Value per Share|CHRO - Net Assets per Single Share|Accounting Value of a Share ELYM|Intra-Cellular Therapies - Net Assets per Single Share|Net Asset Value per Share Longboard LBPH|Accounting Value per Share Marinus Pharmaceuticals MRNS|Net Assets per Single Share nkgenbiotech.com NKGN|Book Value per Share NRBO (NeuroBo Pharmaceuticals, Inc.)|SAGE - Net Assets per Share|Book Value per Share SNPX (Neurotrope)|Trevena Inc (TRVN) - Book Value of One Share|WENA: Book Value per Share|Net Assets per Share CERE